🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Neuroprotective effects of α-lipoic acid on ischemia/reperfusion injury in global cerebral ischemia mouse model.

PMID: 41469453 · DOI: 10.1038/s41598-025-33565-8 · Scientific reports, 2025 · Soyoung Kwak, Ji Sun Lim, Shin Kim, Ye Jin Kwon, Mi-Hee Yu, Mee-Na Park, Dong Kyu Choi, Jeong-Ho Hong, Hae Won Kim
📄 Abstract

Ischemia-reperfusion (I/R) injury, resulting from transient or permanent cerebral vessel occlusion, triggers oxidative stress, neuroinflammation, and blood-brain barrier (BBB) disruption, leading to progressive neuronal damage and cognitive decline. The hippocampus, due to its high metabolic demand and susceptibility to oxidative stress, is particularly vulnerable to I/R-induced injury. This study evaluated the neuroprotective effects of α-lipoic acid (α-LA), a potent antioxidant, using bilateral common carotid arteries occlusion/reperfusion (BCCAO/R) mouse model and an oxygen-glucose deprivation/reoxygenation in vitro model. In BCCAO/R mice, α-LA improved spatial memory without affecting motor activity and restored hippocampal tight junction proteins (Claudin-5 and Occludin) and antioxidant enzyme expression, indicating BBB stabilization and oxidative stress reduction. Although synaptic proteins (BDNF and PSD-95) were not restored, cognitive improvements suggest alternative protective mechanisms. In HT22 cells, α-LA decreased intracellular reactive oxygen species levels, enhanced viability, and inhibited apoptosis via decreased PARP cleavage and caspase-3 activation. These protective effects were linked to the activation of the Nrf2/ARE signaling pathway and the upregulation of its downstream antioxidant targets. Overall, α-LA demonstrated marked neuroprotective effects in ischemic models by reducing oxidative stress, preserving BBB integrity, and restoring hippocampal function, positioning it as a promising therapeutic candidate for ischemic brain injury.

Confidence: 0.24 · 12 полей извлечено
Идентификация (6 полей)
Target
α-lipoic acid
1.00
Alt. target
α-LA
1.00
Protein family
0.00
Functional class
0.00
Subcellular loc.
0.00
Isoforms (metab/obesity)
0.00
Механизм действия (21 полей)
Mechanism
α-Lipoic acid acts as a potent antioxidant, reducing oxidative stress, preserving blood-brain barrier integrity, and restoring hippocampal function. It activates the Nrf2/ARE signaling pathway, upregulating downstream antioxidant targets, and inhibits apoptosis via decreased PARP cleavage and caspase-3 activation.
0.90
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
0.00
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
α-Lipoic acid reduces neuroinflammation in the context of ischemia/reperfusion injury.
0.70
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
0.00
Cell death
α-Lipoic acid inhibits apoptosis via decreased PARP cleavage and caspase-3 activation.
0.90
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
Nrf2/ARE signaling pathway, antioxidant targets, PARP, caspase-3
0.80
Downstream (physiol)
0.00
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
0.00
In vitro
HT22 cells subjected to oxygen-glucose deprivation/reoxygenation
0.95
In vivo
Bilateral common carotid arteries occlusion/reperfusion (BCCAO/R) mouse model
0.95
In silico
0.00
Genetic association
0.00
Ex vivo
0.00
Animal model
Mouse
0.95
Diet/model
Global cerebral ischemia/reperfusion injury model
0.90
Клиника (11 полей)
Drug
α-lipoic acid
1.00
Indication
ischemic brain injury
0.90
Patient subgroups
0.00
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
0.00
Approved
0.00